Complexation of uranyl (UO2)2+ with bidentate ligands: XRD, spectroscopic, computational, and biological studies

Three new uranyl complexes [(UO2)(OAc)2(CMZ)], [(UO2)(OAc)2(MP)] and [(UO2)(OAc)2(SCZ)] were synthesized and characterized by elemental analysis, FT-IR, UV-Vis spectroscopy, powder XRD analysis, and molar conductivity. The IR analysis confirmed binding to the metal ion by the sulfur and ethoxy oxygen atoms in the carbimazole (CMZ) ligand, while in the 6-mercaptopurine (MP) ligand, the sulfur and the N7 nitrogen atom of a purine coordinated binding to the metal ion. The third ligand showed a 1:1 molar ratio and bound via sulfonamide oxygen and the nitrogen of the pyrimidine ring. Analysis of the synthesized complexes also showed that acetate groups had monodentate binding to the (UO22+). Density Functional Theory (DFT) calculations at the B3LYP level showed similar structures to the experimental results. Theoretical quantum parameters predicted the reactivity of the complexes in the order, [(UO2)(OAc)2(SCZ)] > [(UO2)(OAc)2(MP)]> [(UO2)(OAc)2(CMZ)]. DNA binding studies revealed that [(UO2)(OAc)2(SCZ)] and [(UO2)(OAc)2(CMZ)] have the highest binding constant (Kb) among the uranyl complexes. Additionally, strong binding of the MP and CMZ metal complexes to human serum albumin (HSA) were observed by both absorbance and fluorescence approaches. The antibacterial activity of the complexes was also evaluated against four bacterial strains: two gram-negative; Escherichia coli and Klebsiella pneumonia, and two gram-positive; Staphylococcus aureus and Streptococcus mutans. [(UO2)(OAc)2(MP)] had the greatest antibacterial activity against Klebsiella pneumonia, the gram-positive bacteria, with even higher activity than the standard antibiotic. In vitro cytotoxicity tests were also performed against three human cancer lines, and revealed the most cytotoxic complexes to be [(UO2)(OAc)2(SCZ)], which showed moderate activity against a colon cancer cell line. Thus, uranyl addition enhances the antibacterial and anticancer properties of the free ligands.

[1]  A. Emwas,et al.  Practical and Computational Studies of Bivalence Metal Complexes of Sulfaclozine and Biological Studies , 2021, Frontiers in Chemistry.

[2]  M. Hussien,et al.  Bivalence metal complexes of antithyroid drug carbimazole; synthesis, characterization, computational simulation, and biological studies , 2021 .

[3]  Ying-Wu Lin.  Uranyl Binding to Proteins and Structural-Functional Impacts , 2020, Biomolecules.

[4]  Manal Shamsi,et al.  Synthesis and characterization of copper–based anticancer compound; in vitro interaction studies with DNA/HSA, SOD mimetic, cytotoxic activity and molecular docking investigation , 2020, Journal of biomolecular structure & dynamics.

[5]  S. A. Abdel-Latif,et al.  Combined experimental, DFT theoretical calculations and biological activity of sulfaclozine azo dye with 1-hydroxy-2-naphthoic acid and its complexes with some metal ions , 2019, New Journal of Chemistry.

[6]  Xiangxue Wang,et al.  Sensors for determination of uranium: A review , 2019, TrAC Trends in Analytical Chemistry.

[7]  S. Djebbar,et al.  New mixed amino acids complexes of iron(III) and zinc(II) with isonitrosoacetophenone: Synthesis, spectral characterization, DFT study and anticancer activity. , 2019, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[8]  H. El‐Ghamry,et al.  Synthesis, spectroscopic, thermal and molecular modeling studies of Zn2+, Cd2+ and UO22+ complexes of Schiff bases containing triazole moiety. Antimicrobial, anticancer, antioxidant and DNA binding studies. , 2018, Materials science & engineering. C, Materials for biological applications.

[9]  Aubrey N. Nelwamondo,et al.  Comparing results of X-ray diffraction, µ-Raman spectroscopy and neutron diffraction when identifying chemical phases in seized nuclear material, during a comparative nuclear forensics exercise , 2018, Journal of Radioanalytical and Nuclear Chemistry.

[10]  F. Saad,et al.  Density functional theory/B3LYP study of nanometric 4‐(2,4‐dihydroxy‐5‐formylphen‐1‐ylazo)‐N‐(4‐methylpyrimidin‐2‐yl)benzenesulfonamide complexes: Quantitative structure–activity relationship, docking, spectral and biological investigations , 2017 .

[11]  A. El‐Bindary,et al.  Spectroscopic, thermal, catalytic and biological studies of Cu(II) azo dye complexes , 2017 .

[12]  Zeinab Tohidiyan,et al.  Sonochemical, spectroscopic study and antibacterial activity of two uranyl Schiff base complexes in nano scale , 2017, Rendiconti Lincei.

[13]  A. Mishra,et al.  Synthesis and Characterization of Transition Metal complexes with pyrimidine based ligand derivative , 2016 .

[14]  L. Pereira,et al.  Luminescent Properties of [UO2(TFA)2(DMSO)3], a Promising Material for Sensing and Monitoring the Uranyl Ion , 2016 .

[15]  A. Amorim,et al.  Fluorescence and Docking Studies of the Interaction between Human Serum Albumin and Pheophytin , 2015, Molecules.

[16]  F. Saad,et al.  Synthesis, structural characterization, and antimicrobial efficiency of sulfadiazine azo-azomethine dyes and their bi-homonuclear uranyl complexes for chemotherapeutic use , 2015 .

[17]  L. Rao,et al.  Complexation of uranium(VI) with glutarimidoxioxime: thermodynamic and computational studies. , 2015, Dalton transactions.

[18]  B. Sridhar,et al.  XRD, vibrational spectra and quantum chemical studies of an anticancer drug: 6-Mercaptopurine. , 2015, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[19]  A. Kathiravan,et al.  Luminescence and magnetic properties of novel nanoparticle-sheathed 3D Micro-Architectures of Fe0.5R0.5(MoO4)1.5:Ln3+ (R = Gd3+, La3+), (Ln = Eu, Tb, Dy) for bifunctional application , 2015, Electronic Materials Letters.

[20]  R. Kaur,et al.  Anti-cancer pyrimidines in diverse scaffolds: a review of patent literature. , 2014, Recent patents on anti-cancer drug discovery.

[21]  S. Tabassum,et al.  Synthesis and crystal structure determination of copper(II)-complex: In vitro DNA and HSA binding, pBR322 plasmid cleavage, cell imaging and cytotoxic studies. , 2014, European journal of medicinal chemistry.

[22]  S. Rehman,et al.  Interaction of 6 Mercaptopurine with Calf Thymus DNA – Deciphering the Binding Mode and Photoinduced DNA Damage , 2014, PloS one.

[23]  Saqib Ali,et al.  Drug-DNA interactions and their study by UV-Visible, fluorescence spectroscopies and cyclic voltametry. , 2013, Journal of photochemistry and photobiology. B, Biology.

[24]  赵永亮.  Luminescence Properties of Inert lanthanide ion Doped Europium Complexes with 2-Pyrazinecarboxylic Acid and Butanedioic Acid , 2013 .

[25]  L. Rao,et al.  Energetics and structure of uranium(VI)-acetate complexes in dimethyl sulfoxide. , 2012, Inorganic chemistry.

[26]  Saqib Ali,et al.  Synthesis, characterization, biological screenings and interaction with calf thymus DNA as well as electrochemical studies of adducts formed by azomethine [2-((3,5-dimethylphenylimino)methyl)phenol] and organotin(IV) chlorides , 2012 .

[27]  G. Thakur,et al.  Synthesis, Characterization, and Antibacterial Studies of Mixed Ligand Dioxouranium Complexes with 8-Hydroxyquinoline and Some Amino Acids , 2011, ISRN pharmaceutics.

[28]  F. Pavan,et al.  6-Mercaptopurine complexes with silver and gold ions: anti-tuberculosis and anti-cancer activities. , 2011, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[29]  J. Menéndez,et al.  An Overview of Analytical Techniques Employed to Evidence Drug-DNA Interactions. Applications to the Design of Genosensors , 2011 .

[30]  M. J. Chen,et al.  Synthesis, characterization and thermal decomposition of SbIII-M-SbIII type trinuclear complexes of ethylenediamine-N, N, N′, N′-tetraacetate (M:Co(II), La(III), Nd(III), Dy(III)) , 2008 .

[31]  H. Löhmannsröben,et al.  Quantum Dot Nanocrystals and Supramolecular Lanthanide Complexes -Energy Transfer Systems for Sensitive In Vitro Diagnostics and High Throughput Screening in Chemical Biology , 2007 .

[32]  Y. Ikeda,et al.  Structural characterization and reactivity of UO2(salophen)L and [UO2(salophen)]2: dimerization of UO2(salophen) fragments in noncoordinating solvents (salophen = N,N'-disalicylidene-o-phenylenediaminate, L = N,N-dimethylformamide, dimethyl sulfoxide). , 2007, Inorganic chemistry.

[33]  D. Dixon,et al.  Interactions of 1-methylimidazole with UO2(CH3CO2)2 and UO2(NO3)2: structural, spectroscopic, and theoretical evidence for imidazole binding to the uranyl ion. , 2007, Journal of the American Chemical Society.

[34]  Patricia J. Melfi,et al.  Uranium complexes of multidentate N-donor ligands , 2006 .

[35]  Lester R. Morss,et al.  The chemistry of the actinide and transactinide elements , 2006 .

[36]  S. Naik,et al.  Spectroscopic and thermogravimetric studies on Ni(II), Cu(II) and Zn(II) complexes of di(2,6-dichlorophenyl)carbazone , 2002 .

[37]  Z. Tian,et al.  Comparative study of inhibition effects of benzotriazole for metals in neutral solutions as observed with surface-enhanced Raman spectroscopy , 2002 .

[38]  A. S. Luyt,et al.  Synthesis, Fourier transform infrared, nuclear magnetic resonance and thermal analysis of sodium and platinum complexes of 6-mercaptopurine , 2001 .

[39]  N. Turro,et al.  Mixed-ligand complexes of ruthenium(II): factors governing binding to DNA , 1989 .

[40]  M. Kakihana,et al.  Coordination structures for uranyl carboxylate complexes in aqueous solution studied by IR and carbon-13 NMR spectra , 1987 .

[41]  A. El‐Dissouky,et al.  Effect of substituants on the structure of dioxouranium(VI) complexes of 7-carboxaldehyde-8-hydroxyquinoline and some of its Schiff bases , 1986 .

[42]  A. W. Coats,et al.  Thermogravimetric analysis. A review , 1963 .

[43]  S. McGlynn,et al.  Electronic Structure, Spectra, and Magnetic Properties of Oxycations. III. Ligation Effects on the Infrared Spectrum of the Uranyl Ion , 1961 .